Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
J Microbiol Immunol Infect ; 54(1): 109-112, 2021 Feb.
Article in English | MEDLINE | ID: covidwho-813695

ABSTRACT

No specific therapy is available for COVID-19. We report the effectiveness and adverse effects of triple therapy with hydroxychloroquine, azithromycin, and ciclesonide in patients with COVID-19 pneumonia. The clinical condition of the patients improved within 5 days in response to the therapy.


Subject(s)
Antiviral Agents/therapeutic use , Azithromycin/therapeutic use , COVID-19 Drug Treatment , Hydroxychloroquine/therapeutic use , Pregnenediones/therapeutic use , Aged , COVID-19/epidemiology , Drug Therapy, Combination , Female , Humans , Liver/drug effects , Male , Middle Aged , SARS-CoV-2/drug effects , Tokyo/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL